Ionis Pharmaceuticals, Inc.
IONS
$72.33
-$0.01-0.01%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -381.39M | -256.34M | -268.22M | -458.03M | -453.90M |
| Total Depreciation and Amortization | 22.69M | 20.62M | 21.61M | 21.74M | 21.99M |
| Total Amortization of Deferred Charges | 6.91M | 6.61M | 6.64M | 6.67M | 6.69M |
| Total Other Non-Cash Items | 134.42M | 118.55M | 148.90M | 132.89M | 133.66M |
| Change in Net Operating Assets | -51.22M | -136.46M | -139.50M | -205.05M | -209.39M |
| Cash from Operations | -268.58M | -247.01M | -230.57M | -501.78M | -500.95M |
| Capital Expenditure | -51.44M | -55.65M | -59.44M | -53.36M | -45.28M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -226.33M | 265.59M | -162.76M | 13.69M | -88.75M |
| Cash from Investing | -277.78M | 209.94M | -222.19M | -39.67M | -134.03M |
| Total Debt Issued | 770.00M | -- | -- | -- | -- |
| Total Debt Repaid | -267.82M | -44.67M | -44.68M | -44.67M | -44.67M |
| Issuance of Common Stock | 192.60M | 85.22M | 500.05M | 501.36M | 522.73M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -18.95M | -- | -- | -- | -- |
| Cash from Financing | 675.84M | 40.55M | 455.38M | 456.69M | 478.06M |
| Foreign Exchange rate Adjustments | 702.00K | 259.00K | 691.00K | 73.00K | -273.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 130.18M | 3.74M | 3.31M | -84.70M | -157.19M |